KENNEY CHRISTOPHER JOHN

CIK 00018801291 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001880129

Recent Transactions

17 trades

Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-13$55.23/sh−1,410→ 7,069 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-03-12−3,750→ 11,250 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-12+3,750→ 8,479 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-10$60.11/sh−2,771→ 4,729 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-03-09+7,500→ 7,500 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Performance Share Units
2026-03-09−7,500→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Performance Share Units
2026-03-09+7,500→ 7,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2026-01-09+100,000→ 100,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-01-09+20,000→ 20,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-03-12+15,000→ 15,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-03-12+80,000→ 80,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-11+100,000→ 100,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-03-24$35.01/sh−700→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-10+120,000→ 120,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-10+125,000→ 125,000 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-01-21$28.81/sh+700→ 700 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-08-23+150,000→ 150,000 total

Companies

Xenon Pharmaceuticals Inc.
Chief Medical Officer
$XENE

Recent Filings

Address

3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov